(49 days)
The Panosol II Tru-Blu UBL-417 is generally indicated to treat dermatological indications. The Panosol II Tru-Blu UBL-417 is specifically indicated to treat moderate inflammatory Acne Vulgaris
Not Found
I'm sorry, I cannot answer your request with the provided information. The text is a 510(k) clearance letter from the FDA for a phototherapy system. It confirms that the device is substantially equivalent to a predicate device and can be marketed. It does not contain any details about acceptance criteria or a study proving the device meets those criteria, as it is a regulatory document and not a clinical study report.
Therefore, I cannot provide:
- A table of acceptance criteria and reported device performance.
- Sample sizes, data provenance, number of experts, qualifications of experts, adjudication methods for a test set.
- Information about MRMC comparative effectiveness studies or standalone algorithm performance.
- Details about the type of ground truth used or the training set size and ground truth establishment.
§ 878.4630 Ultraviolet lamp for dermatologic disorders.
(a)
Identification. An ultraviolet lamp for dermatologic disorders is a device (including a fixture) intended to provide ultraviolet radiation of the body to photoactivate a drug in the treatment of a dermatologic disorder if the labeling of the drug intended for use with the device bears adequate directions for the device's use with that drug.(b)
Classification. Class II.